Department of Pathology, and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
J Pathol. 2011 Jan;223(2):99-101. doi: 10.1002/path.2812.
Advances in our understanding of cancer biology and discoveries emerging from cancer genomics are being translated into real clinical benefits for patients with cancer. The 2011 Journal of Pathology Annual Review Issue provides a snapshot of recent rapid progress on multiple fronts in the war on cancer or, more precisely, the wars on cancers. Indeed, perhaps the most notable recent shift is reflected by the sharp increase in understanding the biology of multiple specific cancers and using these new insights to inform rationally targeted therapies, with often striking successes. These recent developments, as reviewed in this issue, show how the long-term investments in basic cancer research are finally beginning to bear fruit.
我们对癌症生物学的认识不断提高,癌症基因组学的发现也不断涌现,这些都为癌症患者带来了真正的临床获益。《病理学杂志》2011 年年鉴特刊提供了一个近期在抗癌战场上(或者更确切地说,是在与多种癌症的战斗中)多个方面取得快速进展的快照。事实上,最近最值得注意的转变反映在对多种特定癌症生物学的理解急剧增加,并利用这些新的认识来合理地指导靶向治疗,取得了惊人的成效。本特刊中回顾的这些新进展表明,对癌症基础研究的长期投入终于开始取得成果。